28 employees
Stemson Therapeutics is a pre-clinical stage cell therapy company.
2018
$15M
from 3 investors over 3 rounds
Stemson Therapeutics raised $15M on July 15, 2021
Investors: DCVC Bio and Genoa Ventures
Stemson Therapeutics raised $7.5M on September 16, 2020
Investors: Fortunis Capital Group